| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 7.14e-07 | 5 | 84 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 3.96e-06 | 8 | 84 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.16e-05 | 11 | 84 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 1.99e-05 | 13 | 84 | 3 | GO:0005078 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.53e-05 | 14 | 84 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 5.38e-05 | 231 | 84 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | small GTPase binding | 6.17e-05 | 321 | 84 | 8 | GO:0031267 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 1.04e-04 | 4 | 84 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.37e-04 | 360 | 84 | 8 | GO:0051020 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 1.73e-04 | 5 | 84 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 1.73e-04 | 5 | 84 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 2.59e-04 | 6 | 84 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 2.59e-04 | 6 | 84 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 3.62e-04 | 7 | 84 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 3.91e-04 | 34 | 84 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 4.26e-04 | 35 | 84 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 4.82e-04 | 8 | 84 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 4.82e-04 | 8 | 84 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | oxygen binding | 5.03e-04 | 37 | 84 | 3 | GO:0019825 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity | 7.85e-04 | 43 | 84 | 3 | GO:0004869 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.15e-03 | 49 | 84 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.29e-03 | 51 | 84 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 1.54e-03 | 14 | 84 | 2 | GO:0008195 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 1.77e-03 | 15 | 84 | 2 | GO:0016725 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 2.28e-03 | 17 | 84 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 2.28e-03 | 17 | 84 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.56e-03 | 18 | 84 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | MAP kinase kinase activity | 2.56e-03 | 18 | 84 | 2 | GO:0004708 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 2.60e-03 | 65 | 84 | 3 | GO:0070063 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 2.85e-03 | 19 | 84 | 2 | GO:0042577 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 4.35e-03 | 78 | 84 | 3 | GO:0003725 | |
| GeneOntologyBiologicalProcess | negative regulation of collagen catabolic process | 6.25e-07 | 5 | 83 | 3 | GO:0010711 | |
| GeneOntologyBiologicalProcess | negative regulation of elastin catabolic process | 6.25e-07 | 5 | 83 | 3 | GO:0060311 | |
| GeneOntologyBiologicalProcess | regulation of elastin catabolic process | 1.25e-06 | 6 | 83 | 3 | GO:0060310 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine phosphatase signaling pathway | 2.17e-06 | 7 | 83 | 3 | GO:0007185 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel remodeling | 2.17e-06 | 7 | 83 | 3 | GO:0060313 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte growth | 2.17e-06 | 7 | 83 | 3 | GO:0003430 | |
| GeneOntologyBiologicalProcess | regulation of collagen catabolic process | 5.19e-06 | 9 | 83 | 3 | GO:0010710 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 5.19e-06 | 9 | 83 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | negative regulation of extracellular matrix disassembly | 7.39e-06 | 10 | 83 | 3 | GO:0010716 | |
| GeneOntologyBiologicalProcess | elastin catabolic process | 7.39e-06 | 10 | 83 | 3 | GO:0060309 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte development | 7.39e-06 | 10 | 83 | 3 | GO:0003431 | |
| GeneOntologyBiologicalProcess | chondrocyte hypertrophy | 7.39e-06 | 10 | 83 | 3 | GO:0003415 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 1.35e-05 | 12 | 83 | 3 | GO:0070989 | |
| GeneOntologyBiologicalProcess | chondrocyte development involved in endochondral bone morphogenesis | 1.75e-05 | 13 | 83 | 3 | GO:0003433 | |
| GeneOntologyBiologicalProcess | regulation of axon regeneration | 1.99e-05 | 40 | 83 | 4 | GO:0048679 | |
| GeneOntologyBiologicalProcess | elastin metabolic process | 2.22e-05 | 14 | 83 | 3 | GO:0051541 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte differentiation | 2.22e-05 | 14 | 83 | 3 | GO:0003418 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | PTPRD PTPRF DOCK11 PRKCQ CORO1B DMD IKBKB MAP2K1 MAP2K2 PLCE1 | 2.88e-05 | 494 | 83 | 10 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of neuron projection regeneration | 3.81e-05 | 47 | 83 | 4 | GO:0070570 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation involved in endochondral bone morphogenesis | 6.82e-05 | 20 | 83 | 3 | GO:0003413 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA replication | 8.77e-05 | 58 | 83 | 4 | GO:0045740 | |
| GeneOntologyBiologicalProcess | regulation of Golgi inheritance | 9.55e-05 | 4 | 83 | 2 | GO:0090170 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PTPRD PTPRF TRIO PTPRS SLIT1 CC2D1A PRKCQ CORO1B DMD MAP2K1 MAP2K2 USP33 | 1.03e-04 | 819 | 83 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PTPRD PTPRF TRIO PTPRS SLIT1 CC2D1A PRKCQ CORO1B DMD MAP2K1 MAP2K2 USP33 | 1.11e-04 | 826 | 83 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | demethylation | 1.20e-04 | 24 | 83 | 3 | GO:0070988 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix disassembly | 1.36e-04 | 25 | 83 | 3 | GO:0010715 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | PTPRD PTPRF DOCK11 PTPRS SLIT1 PRKCQ CORO1B DMD IKBKB MAP2K1 MAP2K2 PLCE1 | 1.39e-04 | 846 | 83 | 12 | GO:0120035 |
| GeneOntologyBiologicalProcess | negative regulation of extracellular matrix organization | 1.53e-04 | 26 | 83 | 3 | GO:1903054 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 1.59e-04 | 5 | 83 | 2 | GO:0009822 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | PTPRD PTPRF DOCK11 PTPRS SLIT1 PRKCQ CORO1B DMD IKBKB MAP2K1 MAP2K2 PLCE1 | 1.68e-04 | 863 | 83 | 12 | GO:0031344 |
| GeneOntologyBiologicalProcess | axon regeneration | 1.73e-04 | 69 | 83 | 4 | GO:0031103 | |
| GeneOntologyBiologicalProcess | negative regulation of collagen metabolic process | 1.91e-04 | 28 | 83 | 3 | GO:0010713 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 2.13e-04 | 29 | 83 | 3 | GO:0003417 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.86e-04 | 32 | 83 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of glycoprotein metabolic process | 3.14e-04 | 33 | 83 | 3 | GO:1903019 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 3.20e-04 | 81 | 83 | 4 | GO:0031102 | |
| GeneOntologyBiologicalProcess | trachea formation | 3.32e-04 | 7 | 83 | 2 | GO:0060440 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PTPRD PTPRF TRIO PTPRS SLIT1 CC2D1A PRKCQ DMD MAP2K1 MAP2K2 USP33 | 3.60e-04 | 802 | 83 | 11 | GO:0048812 |
| GeneOntologyBiologicalProcess | endochondral bone growth | 5.17e-04 | 39 | 83 | 3 | GO:0003416 | |
| GeneOntologyBiologicalProcess | regeneration | 5.39e-04 | 252 | 83 | 6 | GO:0031099 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 5.58e-04 | 40 | 83 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | alkaloid metabolic process | 5.65e-04 | 9 | 83 | 2 | GO:0009820 | |
| GeneOntologyBiologicalProcess | chondrocyte development | 6.00e-04 | 41 | 83 | 3 | GO:0002063 | |
| GeneOntologyBiologicalProcess | glycoprotein catabolic process | 6.00e-04 | 41 | 83 | 3 | GO:0006516 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 6.44e-04 | 42 | 83 | 3 | GO:0099560 | |
| GeneOntologyBiologicalProcess | replacement ossification | 6.90e-04 | 43 | 83 | 3 | GO:0036075 | |
| GeneOntologyBiologicalProcess | endochondral ossification | 6.90e-04 | 43 | 83 | 3 | GO:0001958 | |
| GeneOntologyBiologicalProcess | nucleus localization | 7.39e-04 | 44 | 83 | 3 | GO:0051647 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 7.39e-04 | 44 | 83 | 3 | GO:0001580 | |
| GeneOntologyBiologicalProcess | bone growth | 7.89e-04 | 45 | 83 | 3 | GO:0098868 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PTPRD PTPRF TRIO PTPRS SLIT1 CC2D1A PRKCQ MAP2K1 MAP2K2 USP33 | 8.26e-04 | 748 | 83 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | response to axon injury | 8.56e-04 | 105 | 83 | 4 | GO:0048678 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 8.97e-04 | 47 | 83 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 8.97e-04 | 47 | 83 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | 9.54e-04 | 48 | 83 | 3 | GO:0050913 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in lung morphogenesis | 1.03e-03 | 12 | 83 | 2 | GO:0060502 | |
| GeneOntologyBiologicalProcess | trachea morphogenesis | 1.03e-03 | 12 | 83 | 2 | GO:0060439 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | SETDB2 THBS2 ANKFY1 PTPRD PTPRF DOCK11 PRKCQ CORO1B DMD IKBKB MAP2K1 MAP2K2 DYNC1H1 PLCE1 | 1.04e-03 | 1366 | 83 | 14 | GO:0051130 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 1.07e-03 | 50 | 83 | 3 | GO:0050912 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.20e-03 | 52 | 83 | 3 | GO:0008210 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 1.21e-03 | 13 | 83 | 2 | GO:0038133 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 1.27e-03 | 53 | 83 | 3 | GO:0030574 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.34e-03 | 202 | 83 | 5 | GO:0051963 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | THBS2 AGO1 PTPRD PTPRF PTPRS SLIT1 CST1 CST2 CST4 CORO1B MAP2K1 MAP2K2 | 1.34e-03 | 1090 | 83 | 12 | GO:0022603 |
| GeneOntologyBiologicalProcess | developmental cell growth | 1.35e-03 | 301 | 83 | 6 | GO:0048588 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 1.41e-03 | 14 | 83 | 2 | GO:0038129 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | 1.44e-03 | 538 | 83 | 8 | GO:0007264 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.55e-03 | 309 | 83 | 6 | GO:1901888 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 1.65e-03 | 58 | 83 | 3 | GO:0097106 | |
| GeneOntologyCellularComponent | basement membrane | 1.41e-04 | 122 | 85 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH13 EFCAB6 CST1 CST2 TPX2 CST4 AKAP13 KLHL41 CORO1B DMD MAP2K1 MAP2K2 DYNC1H1 DNAH14 | 2.70e-04 | 1179 | 85 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH13 EFCAB6 CST1 CST2 TPX2 CST4 AKAP13 KLHL41 CORO1B DMD MAP2K1 MAP2K2 DYNC1H1 DNAH14 | 2.90e-04 | 1187 | 85 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | neuronal cell body | PTPRF KCNC1 PTPRS CST1 CST2 TPX2 CST4 DMD MAP2K1 DYNC1H1 USP33 | 5.56e-04 | 835 | 85 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | granular component | 5.77e-04 | 9 | 85 | 2 | GO:0001652 | |
| GeneOntologyCellularComponent | axon | AGBL4 PTPRF KCNC1 PTPRS CST1 CST2 TPX2 CST4 DMD MAP2K1 DYNC1H1 | 9.49e-04 | 891 | 85 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.18e-03 | 290 | 85 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | cell body | PTPRF KCNC1 PTPRS CST1 CST2 TPX2 CST4 DMD MAP2K1 DYNC1H1 USP33 | 1.33e-03 | 929 | 85 | 11 | GO:0044297 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GBP7 CST1 CST2 CST4 OAS2 AKAP13 CORO1B DMD MAP2K1 MAP2K2 USP33 | 1.39e-03 | 934 | 85 | 11 | GO:0048471 |
| MousePheno | abnormal long bone epiphysis morphology | 1.28e-05 | 30 | 68 | 4 | MP:0000131 | |
| MousePheno | loss of hippocampal neurons | 2.35e-05 | 12 | 68 | 3 | MP:0003240 | |
| MousePheno | increased metastatic potential | 3.34e-05 | 38 | 68 | 4 | MP:0001272 | |
| MousePheno | decreased susceptibility to ischemic brain injury | 9.20e-05 | 49 | 68 | 4 | MP:0006059 | |
| MousePheno | decreased response to brain injury | 9.20e-05 | 49 | 68 | 4 | MP:0014522 | |
| MousePheno | small superior vagus ganglion | 1.18e-04 | 20 | 68 | 3 | MP:0001102 | |
| MousePheno | abnormal superior vagus ganglion morphology | 1.82e-04 | 23 | 68 | 3 | MP:0001101 | |
| MousePheno | decreased trabecular bone volume | 2.03e-04 | 60 | 68 | 4 | MP:0010879 | |
| MousePheno | abnormal metastatic potential | 2.61e-04 | 64 | 68 | 4 | MP:0000858 | |
| MousePheno | abnormal interleukin-6 secretion | 2.83e-04 | 186 | 68 | 6 | MP:0008704 | |
| Domain | Cyt_P450_E_grp-II | 8.72e-07 | 5 | 84 | 3 | IPR002402 | |
| Domain | Cyt_P450_E_CYP3A | 1.74e-06 | 6 | 84 | 3 | IPR008072 | |
| Domain | Prot_inh_cystat_CS | 7.23e-06 | 9 | 84 | 3 | IPR018073 | |
| Domain | Spectrin/alpha-actinin | 1.24e-05 | 32 | 84 | 4 | IPR018159 | |
| Domain | SPEC | 1.24e-05 | 32 | 84 | 4 | SM00150 | |
| Domain | Cystatin | 1.88e-05 | 12 | 84 | 3 | IPR027214 | |
| Domain | CYSTATIN | 1.88e-05 | 12 | 84 | 3 | PS00287 | |
| Domain | CY | 5.70e-05 | 17 | 84 | 3 | SM00043 | |
| Domain | Lipin_N | 5.98e-05 | 3 | 84 | 2 | IPR007651 | |
| Domain | Lipin_mid | 5.98e-05 | 3 | 84 | 2 | PF16876 | |
| Domain | Lipin_mid | 5.98e-05 | 3 | 84 | 2 | IPR031703 | |
| Domain | Lipin_N | 5.98e-05 | 3 | 84 | 2 | PF04571 | |
| Domain | - | 6.49e-05 | 391 | 84 | 9 | 2.30.29.30 | |
| Domain | Cystatin_dom | 6.82e-05 | 18 | 84 | 3 | IPR000010 | |
| Domain | Cystatin | 6.82e-05 | 18 | 84 | 3 | PF00031 | |
| Domain | PH_dom-like | 1.25e-04 | 426 | 84 | 9 | IPR011993 | |
| Domain | Spectrin | 1.46e-04 | 23 | 84 | 3 | PF00435 | |
| Domain | DH_1 | 1.85e-04 | 63 | 84 | 4 | PS00741 | |
| Domain | SEC14 | 1.88e-04 | 25 | 84 | 3 | SM00516 | |
| Domain | CRAL_TRIO | 2.37e-04 | 27 | 84 | 3 | PS50191 | |
| Domain | RhoGEF | 2.49e-04 | 68 | 84 | 4 | SM00325 | |
| Domain | CRAL-TRIO_dom | 2.65e-04 | 28 | 84 | 3 | IPR001251 | |
| Domain | RhoGEF | 2.78e-04 | 70 | 84 | 4 | PF00621 | |
| Domain | DH_2 | 2.78e-04 | 70 | 84 | 4 | PS50010 | |
| Domain | DH-domain | 2.94e-04 | 71 | 84 | 4 | IPR000219 | |
| Domain | - | 2.94e-04 | 71 | 84 | 4 | 1.20.900.10 | |
| Domain | Spectrin_repeat | 2.95e-04 | 29 | 84 | 3 | IPR002017 | |
| Domain | LNS2 | 2.96e-04 | 6 | 84 | 2 | PF08235 | |
| Domain | LNS2 | 2.96e-04 | 6 | 84 | 2 | IPR013209 | |
| Domain | LNS2 | 2.96e-04 | 6 | 84 | 2 | SM00775 | |
| Domain | LNS2/PITP | 2.96e-04 | 6 | 84 | 2 | IPR031315 | |
| Domain | PTPc | 5.63e-04 | 36 | 84 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 7.14e-04 | 39 | 84 | 3 | PS50055 | |
| Domain | PTPase_domain | 8.27e-04 | 41 | 84 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 8.27e-04 | 41 | 84 | 3 | PF00102 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.04e-03 | 99 | 84 | 4 | IPR029021 | |
| Domain | CRAL_TRIO_2 | 1.28e-03 | 12 | 84 | 2 | PF13716 | |
| Domain | PH | 1.59e-03 | 278 | 84 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 1.62e-03 | 279 | 84 | 6 | PS50003 | |
| Domain | PH_domain | 1.65e-03 | 280 | 84 | 6 | IPR001849 | |
| Domain | Cyt_P450_CS | 1.75e-03 | 53 | 84 | 3 | IPR017972 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.76e-03 | 14 | 84 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.76e-03 | 14 | 84 | 2 | IPR024743 | |
| Domain | Znf_UBP | 1.76e-03 | 14 | 84 | 2 | IPR001607 | |
| Domain | MT | 1.76e-03 | 14 | 84 | 2 | PF12777 | |
| Domain | AAA_8 | 1.76e-03 | 14 | 84 | 2 | PF12780 | |
| Domain | zf-UBP | 1.76e-03 | 14 | 84 | 2 | PF02148 | |
| Domain | ZF_UBP | 1.76e-03 | 14 | 84 | 2 | PS50271 | |
| Domain | DHC_fam | 2.02e-03 | 15 | 84 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.02e-03 | 15 | 84 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.02e-03 | 15 | 84 | 2 | PF03028 | |
| Domain | CYTOCHROME_P450 | 2.16e-03 | 57 | 84 | 3 | PS00086 | |
| Domain | p450 | 2.27e-03 | 58 | 84 | 3 | PF00067 | |
| Domain | PTPc_motif | 2.38e-03 | 59 | 84 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.38e-03 | 59 | 84 | 3 | IPR003595 | |
| Domain | Cyt_P450 | 2.50e-03 | 60 | 84 | 3 | IPR001128 | |
| Domain | PH | 3.73e-03 | 229 | 84 | 5 | PF00169 | |
| Domain | C2 | 3.86e-03 | 142 | 84 | 4 | PS50004 | |
| Domain | Tyr_Pase_AS | 4.35e-03 | 73 | 84 | 3 | IPR016130 | |
| Domain | - | 4.47e-03 | 148 | 84 | 4 | 2.60.40.150 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 9.19e-05 | 20 | 63 | 3 | M27290 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 9.19e-05 | 20 | 63 | 3 | MM15485 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 9.19e-05 | 20 | 63 | 3 | MM14991 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.07e-04 | 21 | 63 | 3 | M27736 | |
| Pathway | WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN | 1.07e-04 | 21 | 63 | 3 | M48342 | |
| Pathway | REACTOME_XENOBIOTICS | 1.41e-04 | 23 | 63 | 3 | M5372 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.41e-04 | 23 | 63 | 3 | MM16639 | |
| Pathway | WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION | 1.66e-04 | 62 | 63 | 4 | M39429 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY | 1.95e-04 | 5 | 63 | 2 | M49016 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 2.86e-04 | 29 | 63 | 3 | M2920 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 2.91e-04 | 6 | 63 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 2.91e-04 | 6 | 63 | 2 | MM15273 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 2.91e-04 | 6 | 63 | 2 | M47636 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 3.47e-04 | 75 | 63 | 4 | M39568 | |
| Pathway | PID_NETRIN_PATHWAY | 3.85e-04 | 32 | 63 | 3 | M108 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 5.41e-04 | 8 | 63 | 2 | MM1547 | |
| Pathway | PID_GMCSF_PATHWAY | 5.47e-04 | 36 | 63 | 3 | M22 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 5.59e-04 | 85 | 63 | 4 | MM14746 | |
| Pathway | WP_TCELL_ACTIVATION_SARSCOV2 | 6.38e-04 | 88 | 63 | 4 | M42580 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 6.93e-04 | 39 | 63 | 3 | M39905 | |
| Pathway | WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1 | 6.93e-04 | 9 | 63 | 2 | M39481 | |
| Pathway | WP_TCELL_RECEPTOR_SIGNALING | 6.94e-04 | 90 | 63 | 4 | M39725 | |
| Pathway | WP_INSULIN_SIGNALING | 7.32e-04 | 160 | 63 | 5 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 7.32e-04 | 160 | 63 | 5 | M39482 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY | 8.64e-04 | 10 | 63 | 2 | M47374 | |
| Pathway | KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY | 8.64e-04 | 10 | 63 | 2 | M47420 | |
| Pathway | WP_ETHANOL_METABOLISM_RESULTING_IN_PRODUCTION_OF_ROS_BY_CYP2E1 | 8.64e-04 | 10 | 63 | 2 | MM15821 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY | 8.64e-04 | 10 | 63 | 2 | M47735 | |
| Pathway | REACTOME_PREDNISONE_ADME | 8.64e-04 | 10 | 63 | 2 | M46430 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 9.20e-04 | 97 | 63 | 4 | M9400 | |
| Pathway | WP_IL11_SIGNALING | 9.89e-04 | 44 | 63 | 3 | M39716 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 9.89e-04 | 44 | 63 | 3 | M875 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.05e-03 | 11 | 63 | 2 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.05e-03 | 11 | 63 | 2 | M47371 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS | 1.05e-03 | 11 | 63 | 2 | M27420 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.06e-03 | 45 | 63 | 3 | MM15694 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.13e-03 | 46 | 63 | 3 | M19118 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.13e-03 | 46 | 63 | 3 | MM1428 | |
| Pathway | PID_RHOA_REG_PATHWAY | 1.13e-03 | 46 | 63 | 3 | M68 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.26e-03 | 12 | 63 | 2 | M47369 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 1.26e-03 | 12 | 63 | 2 | M47597 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 1.26e-03 | 12 | 63 | 2 | MM15105 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 1.26e-03 | 12 | 63 | 2 | M47815 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 1.26e-03 | 12 | 63 | 2 | MM14586 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 1.26e-03 | 12 | 63 | 2 | MM15447 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.26e-03 | 12 | 63 | 2 | MM15616 | |
| Pathway | WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY | 1.35e-03 | 49 | 63 | 3 | M39543 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.37e-03 | 108 | 63 | 4 | M9904 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 1.49e-03 | 13 | 63 | 2 | M47589 | |
| Pathway | BIOCARTA_CDK5_PATHWAY | 1.49e-03 | 13 | 63 | 2 | M89 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 1.49e-03 | 13 | 63 | 2 | M656 | |
| Pathway | WP_OSTEOPONTIN_SIGNALING | 1.49e-03 | 13 | 63 | 2 | M39603 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.52e-03 | 51 | 63 | 3 | M17726 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.61e-03 | 52 | 63 | 3 | MM14743 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 1.73e-03 | 14 | 63 | 2 | M668 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.73e-03 | 14 | 63 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 1.73e-03 | 14 | 63 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.73e-03 | 14 | 63 | 2 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.73e-03 | 14 | 63 | 2 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 1.73e-03 | 14 | 63 | 2 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 1.73e-03 | 14 | 63 | 2 | M47384 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 1.73e-03 | 14 | 63 | 2 | M619 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 1.73e-03 | 14 | 63 | 2 | M622 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 1.73e-03 | 14 | 63 | 2 | MM14667 | |
| Pathway | BIOCARTA_CDK5_PATHWAY | 1.73e-03 | 14 | 63 | 2 | MM1457 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.73e-03 | 14 | 63 | 2 | M47488 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 1.73e-03 | 14 | 63 | 2 | MM1489 | |
| Pathway | WP_IL1_SIGNALING | 1.89e-03 | 55 | 63 | 3 | M39346 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 1.89e-03 | 55 | 63 | 3 | M39685 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.89e-03 | 55 | 63 | 3 | M14933 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47375 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47382 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47380 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 1.99e-03 | 15 | 63 | 2 | M27360 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M47531 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.99e-03 | 15 | 63 | 2 | MM15697 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.99e-03 | 15 | 63 | 2 | MM14965 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.02e-03 | 120 | 63 | 4 | MM14982 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 2.10e-03 | 57 | 63 | 3 | M19888 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.27e-03 | 16 | 63 | 2 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.27e-03 | 16 | 63 | 2 | M47373 | |
| Pathway | REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION | 2.27e-03 | 16 | 63 | 2 | M27567 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 2.27e-03 | 16 | 63 | 2 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 2.27e-03 | 16 | 63 | 2 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 2.27e-03 | 16 | 63 | 2 | M47801 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 2.27e-03 | 16 | 63 | 2 | M39882 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 2.27e-03 | 16 | 63 | 2 | M47483 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 1.41e-08 | 3 | 85 | 3 | 31985401 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 20139422 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 9784606 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 1.41e-08 | 3 | 85 | 3 | 33656439 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 1898352 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 1471486 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 1778989 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 8524829 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 10713450 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 13679380 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 23671283 | ||
| Pubmed | Cystatin C stimulates the differentiation of mouse osteoblastic cells and bone formation. | 1.40e-07 | 5 | 85 | 3 | 17592728 | |
| Pubmed | Obesity-Induced Increase in Cystatin C Alleviates Tissue Inflammation. | 1.40e-07 | 5 | 85 | 3 | 32616516 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 10780709 | ||
| Pubmed | Cystatin C Deficiency Increases LPS-Induced Sepsis and NLRP3 Inflammasome Activation in Mice. | 1.40e-07 | 5 | 85 | 3 | 34440840 | |
| Pubmed | Transforming growth factor beta regulates cystatin C in serum-free mouse embryo (SFME) cells. | 1.40e-07 | 5 | 85 | 3 | 2241983 | |
| Pubmed | Strong conservation of the expression of cystatin C gene in choroid plexus. | 1.40e-07 | 5 | 85 | 3 | 1636787 | |
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 1.40e-07 | 5 | 85 | 3 | 11266076 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 15450354 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 21443774 | ||
| Pubmed | Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis. | 1.40e-07 | 5 | 85 | 3 | 27079462 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 10748866 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 15823274 | ||
| Pubmed | Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice. | 1.40e-07 | 5 | 85 | 3 | 21085595 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 34914637 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 16595632 | ||
| Pubmed | Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation. | 1.40e-07 | 5 | 85 | 3 | 20489058 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 10777529 | ||
| Pubmed | Neuroprotection mediated by cystatin C-loaded extracellular vesicles. | 1.40e-07 | 5 | 85 | 3 | 31367000 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 12044447 | ||
| Pubmed | FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. | 1.40e-07 | 5 | 85 | 3 | 11144350 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 22357843 | ||
| Pubmed | Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution. | 1.40e-07 | 5 | 85 | 3 | 8761177 | |
| Pubmed | Cystatin C triggers neuronal degeneration in a model of multiple system atrophy. | 1.40e-07 | 5 | 85 | 3 | 24405769 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 14742906 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 19773092 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 33754041 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 24570004 | ||
| Pubmed | Loss of cystatin C regulates permeability and inflammatory pathways in retina. | 1.40e-07 | 5 | 85 | 3 | 36822364 | |
| Pubmed | Dissecting the Genetic Architecture of Cystatin C in Diversity Outbred Mice. | 1.40e-07 | 5 | 85 | 3 | 32467129 | |
| Pubmed | Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse. | 1.40e-07 | 5 | 85 | 3 | 16242633 | |
| Pubmed | Carminerin contributes to chondrocyte calcification during endochondral ossification. | 1.40e-07 | 5 | 85 | 3 | 16680148 | |
| Pubmed | Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune Encephalomyelitis. | 1.40e-07 | 5 | 85 | 3 | 33027652 | |
| Pubmed | pH-dependent and dynamic interactions of cystatin C with heparan sulfate. | 1.40e-07 | 5 | 85 | 3 | 33580179 | |
| Pubmed | CST3 alleviates retinal vascular leakage by regulating the Rap1 signaling pathway. | 1.40e-07 | 5 | 85 | 3 | 39147193 | |
| Pubmed | Evolution of C, D and S-type cystatins in mammals: an extensive gene duplication in primates. | 1.40e-07 | 5 | 85 | 3 | 25329717 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 24500719 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 20472891 | ||
| Pubmed | Control and expression of cystatin C by mouse decidual cultures. | 1.40e-07 | 5 | 85 | 3 | 11803549 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 16051881 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 19273906 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 14607896 | ||
| Pubmed | Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis. | 2.80e-07 | 6 | 85 | 3 | 29724997 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 25356866 | ||
| Pubmed | Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. | 2.80e-07 | 6 | 85 | 3 | 16365041 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 11879580 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 20889561 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 18026102 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 26592151 | ||
| Pubmed | Megalin-mediated endocytosis of cystatin C in proximal tubule cells. | 2.80e-07 | 6 | 85 | 3 | 17462596 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 20352108 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 15653570 | ||
| Pubmed | Macrophage responses to interferon-gamma are dependent on cystatin C levels. | 2.80e-07 | 6 | 85 | 3 | 19446036 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 11472890 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 29073098 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 12376545 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 27693425 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 31513306 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 10229662 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 18957217 | ||
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 4.90e-07 | 7 | 85 | 3 | 11137287 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 7835704 | ||
| Pubmed | Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein. | 4.90e-07 | 7 | 85 | 3 | 23024364 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 21300820 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 18681831 | ||
| Pubmed | Isolation of cystatin C via functional cloning of astrocyte differentiation factors. | 4.90e-07 | 7 | 85 | 3 | 15509901 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 20093401 | ||
| Pubmed | Genomic cloning, physical mapping, and expression of human type 2 cystatin genes. | 7.82e-07 | 8 | 85 | 3 | 7690606 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 11856874 | ||
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 37591863 | ||
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 28637841 | ||
| Pubmed | PKCθ and HIV-1 Transcriptional Regulator Tat Co-exist at the LTR Promoter in CD4(+) T Cells. | 7.82e-07 | 8 | 85 | 3 | 26973648 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 9310336 | ||
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 3917435 | ||
| Pubmed | Translational deregulation in PDK-1-/- embryonic stem cells. | 1.17e-06 | 9 | 85 | 3 | 16166629 | |
| Pubmed | Induced expression of cathepsins and cystatin C in a murine model of demyelination. | 1.17e-06 | 9 | 85 | 3 | 17086443 | |
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 23555914 | ||
| Pubmed | Direct mapping of seven genes encoding human type 2 cystatins to a single site located at 20p11.2. | 1.67e-06 | 10 | 85 | 3 | 7896273 | |
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 3202964 | ||
| Pubmed | Iron deficiency alters expression of genes implicated in Alzheimer disease pathogenesis. | 1.67e-06 | 10 | 85 | 3 | 18723004 | |
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 14516662 | ||
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 25624497 | ||
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 7832766 | ||
| Pubmed | Testatin: a cystatin-related gene expressed during early testis development. | 2.29e-06 | 11 | 85 | 3 | 9826679 | |
| Pubmed | Role of the Drug-Metabolizing Enzyme CYP during Mouse Liver Development. | 2.29e-06 | 11 | 85 | 3 | 27904043 | |
| Pubmed | Salivary protein profiles are linked to bitter taste acceptance in infants. | 2.29e-06 | 11 | 85 | 3 | 24248522 | |
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 2.30e-06 | 38 | 85 | 4 | 12482669 | |
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 10707901 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 3.05e-06 | 12 | 85 | 3 | 9624153 | |
| Pubmed | Friends and relations of the cystatin superfamily--new members and their evolution. | 3.05e-06 | 12 | 85 | 3 | 9007972 | |
| Interaction | AKNAD1 interactions | 1.39e-05 | 12 | 82 | 3 | int:AKNAD1 | |
| Interaction | CRYGN interactions | 1.39e-05 | 12 | 82 | 3 | int:CRYGN | |
| Interaction | TGFBR2 interactions | 1.62e-05 | 275 | 82 | 8 | int:TGFBR2 | |
| Interaction | OMG interactions | 1.80e-05 | 13 | 82 | 3 | int:OMG | |
| Interaction | RHOBTB1 interactions | 3.64e-05 | 152 | 82 | 6 | int:RHOBTB1 | |
| Interaction | KCNG4 interactions | 5.07e-05 | 18 | 82 | 3 | int:KCNG4 | |
| Interaction | RCAN1 interactions | 5.94e-05 | 52 | 82 | 4 | int:RCAN1 | |
| Interaction | PLEKHG6 interactions | 6.41e-05 | 53 | 82 | 4 | int:PLEKHG6 | |
| Interaction | DAZ2 interactions | 8.19e-05 | 21 | 82 | 3 | int:DAZ2 | |
| Interaction | TRIO interactions | 8.27e-05 | 109 | 82 | 5 | int:TRIO | |
| Interaction | CHAC2 interactions | 9.46e-05 | 22 | 82 | 3 | int:CHAC2 | |
| Interaction | ZNF491 interactions | 1.08e-04 | 23 | 82 | 3 | int:ZNF491 | |
| Interaction | RCAN2 interactions | 1.24e-04 | 24 | 82 | 3 | int:RCAN2 | |
| Interaction | PDZRN4 interactions | 1.62e-04 | 5 | 82 | 2 | int:PDZRN4 | |
| Cytoband | 20p11.21 | 3.21e-05 | 33 | 85 | 3 | 20p11.21 | |
| Cytoband | 7q21.1 | 9.42e-05 | 8 | 85 | 2 | 7q21.1 | |
| Cytoband | 4p15.32 | 4.00e-04 | 16 | 85 | 2 | 4p15.32 | |
| GeneFamily | Cytochrome P450 family 3 | 2.02e-06 | 8 | 61 | 3 | 1002 | |
| GeneFamily | Cystatins, type 2 | 1.98e-05 | 16 | 61 | 3 | 965 | |
| GeneFamily | Lipins | 3.35e-05 | 3 | 61 | 2 | 1043 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.65e-05 | 21 | 61 | 3 | 813 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.23e-05 | 66 | 61 | 4 | 722 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 2.33e-04 | 7 | 61 | 2 | 653 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.13e-03 | 161 | 61 | 4 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.15e-03 | 206 | 61 | 4 | 682 | |
| Coexpression | XU_CREBBP_TARGETS_UP | 6.87e-07 | 22 | 84 | 4 | M17669 | |
| Coexpression | XU_CREBBP_TARGETS_UP | 8.30e-07 | 23 | 84 | 4 | MM641 | |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP | 3.74e-06 | 200 | 84 | 7 | M9030 | |
| Coexpression | GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN | 3.74e-06 | 200 | 84 | 7 | M7336 | |
| Coexpression | VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN | 1.73e-05 | 16 | 84 | 3 | M11619 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 2.29e-05 | 177 | 84 | 6 | M9401 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 2.75e-05 | 54 | 84 | 4 | MM715 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP | 4.54e-05 | 200 | 84 | 6 | M9051 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | AGBL4 TRIO PTPRS CDKN2AIP CST1 CST2 CST4 AKAP13 CORO1B DMD MAP2K2 MTMR10 | 5.11e-05 | 954 | 84 | 12 | MM3689 |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 6.12e-05 | 24 | 84 | 3 | MM3779 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_EPITHELIAL_CELL_AGEING | 6.12e-05 | 24 | 84 | 3 | MM3723 | |
| Coexpression | BMI1_DN_MEL18_DN.V1_DN | 1.12e-04 | 147 | 84 | 5 | M2775 | |
| Coexpression | BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE | 1.17e-04 | 78 | 84 | 4 | M2532 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 189 | 84 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.57e-06 | 189 | 84 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 158 | 84 | 5 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-05 | 170 | 84 | 5 | 8e9b5f7bfb61f8d84d0b17fb0c191da4dabad63d | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.97e-05 | 174 | 84 | 5 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 175 | 84 | 5 | f949613ee45f5d950578c512d197716855118d18 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 176 | 84 | 5 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 177 | 84 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.44e-05 | 182 | 84 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-05 | 183 | 84 | 5 | 6e5b39c0170d62eb7fdd411dcfff51ed176573d0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 183 | 84 | 5 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 84 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 84 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 84 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-05 | 185 | 84 | 5 | 9878392d79734ab5bb977d7f4f5e2e079b9a5353 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.64e-05 | 185 | 84 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.85e-05 | 188 | 84 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 188 | 84 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 188 | 84 | 5 | 794fc1d9a726945c42f7eac221eed938309b47a9 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.93e-05 | 189 | 84 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.93e-05 | 189 | 84 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-05 | 191 | 84 | 5 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 191 | 84 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 191 | 84 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.08e-05 | 191 | 84 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.08e-05 | 191 | 84 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.08e-05 | 191 | 84 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.32e-05 | 194 | 84 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 194 | 84 | 5 | 70185c0b8e0f4e896645b17a243482ba3cdf4a5d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-05 | 194 | 84 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.40e-05 | 195 | 84 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.40e-05 | 195 | 84 | 5 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.40e-05 | 195 | 84 | 5 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-05 | 196 | 84 | 5 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 3.48e-05 | 196 | 84 | 5 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 3.57e-05 | 197 | 84 | 5 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 197 | 84 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 3.65e-05 | 198 | 84 | 5 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 3.65e-05 | 198 | 84 | 5 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-05 | 199 | 84 | 5 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-05 | 199 | 84 | 5 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-05 | 199 | 84 | 5 | 801887db51ac5dc5b068808ff75e3a46643398e9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 200 | 84 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.83e-05 | 200 | 84 | 5 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.67e-05 | 123 | 84 | 4 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-04 | 150 | 84 | 4 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | Influenza_Severe-Treg|Influenza_Severe / Disease group and Cell class | 2.06e-04 | 154 | 84 | 4 | 77845bcb243aa1b1f1ca00f9ef2ae1b4d1bd3696 | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | ab9c17f86b98e1a4d5db1bd3086edab1320ebda8 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.62e-04 | 164 | 84 | 4 | f88871d3b9307112eb7ced4c629f5704326ecae8 | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 2.62e-04 | 164 | 84 | 4 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 2.68e-04 | 165 | 84 | 4 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-04 | 167 | 84 | 4 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 168 | 84 | 4 | 9d6ca10c272aea28082c09d469940f7232f6461c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-04 | 169 | 84 | 4 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-04 | 169 | 84 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD4_CTL|ICU-NoSEP / Disease, Lineage and Cell Type | 2.93e-04 | 169 | 84 | 4 | cbda36f32bd78322dcfe303a44413415d08e5ea3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-04 | 169 | 84 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.07e-04 | 171 | 84 | 4 | a8adce007ff4c713f71f2359b40cb3575b28c98d | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-04 | 172 | 84 | 4 | 714172f31abd0d25261df6115ec6a9df491fa14b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 173 | 84 | 4 | 9f892d756d05e573af018db64edb130ff187ad47 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 174 | 84 | 4 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-04 | 174 | 84 | 4 | 99d7421ad5eafe7751ef90698a92f683aa33bca8 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 174 | 84 | 4 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.42e-04 | 176 | 84 | 4 | b794275fdd757b8fa2108e3c867f23da2649146d | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-04 | 176 | 84 | 4 | a23d484aff5ad094333b2feae9106ca219514711 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 3.42e-04 | 176 | 84 | 4 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-04 | 177 | 84 | 4 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 177 | 84 | 4 | 52402ff6299210c46fd9dee3cef203c0eda7a98a | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 177 | 84 | 4 | f10f77130dbb2c0ad1b436ceb4fb1deac2b0267c | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 3.50e-04 | 177 | 84 | 4 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 177 | 84 | 4 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-04 | 177 | 84 | 4 | 01df8ab3285fa66b4805c555cfbfc4b3b16db919 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 178 | 84 | 4 | b169aa5eaa51730daaec69c6bc58126be1592a50 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 3.57e-04 | 178 | 84 | 4 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 178 | 84 | 4 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.57e-04 | 178 | 84 | 4 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.65e-04 | 179 | 84 | 4 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-04 | 179 | 84 | 4 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-04 | 179 | 84 | 4 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-04 | 179 | 84 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-04 | 180 | 84 | 4 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.72e-04 | 180 | 84 | 4 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 181 | 84 | 4 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.80e-04 | 181 | 84 | 4 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 181 | 84 | 4 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 181 | 84 | 4 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-04 | 181 | 84 | 4 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.80e-04 | 181 | 84 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-04 | 182 | 84 | 4 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 182 | 84 | 4 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-04 | 183 | 84 | 4 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 3.96e-04 | 183 | 84 | 4 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 3.96e-04 | 183 | 84 | 4 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.96e-04 | 183 | 84 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.96e-04 | 183 | 84 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| Drug | PD 0325901 | 4.08e-06 | 114 | 84 | 6 | ctd:C506614 | |
| Drug | Mangifera indica extract | 5.73e-06 | 32 | 84 | 4 | ctd:C501277 | |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A | 8.14e-06 | 196 | 84 | 7 | 6653_DN | |
| Drug | AC1L1CJI | 8.27e-06 | 35 | 84 | 4 | CID000001929 | |
| Drug | TAK 733 | 1.35e-05 | 2 | 84 | 2 | ctd:C558666 | |
| Drug | Methacrol 2138F | 1.35e-05 | 2 | 84 | 2 | CID000161664 | |
| Drug | Sulfoglycosphingolipids | 1.35e-05 | 2 | 84 | 2 | ctd:D013433 | |
| Drug | gemfibrozil glucuronide | 1.35e-05 | 2 | 84 | 2 | CID000088127 | |
| Drug | N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | 1.35e-05 | 2 | 84 | 2 | ctd:C544830 | |
| Drug | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 2.96e-05 | 48 | 84 | 4 | ctd:C120227 | |
| Drug | naphthalene epoxide | 3.77e-05 | 51 | 84 | 4 | CID000108063 | |
| Drug | AC1L1SX8 | 3.80e-05 | 18 | 84 | 3 | CID000060278 | |
| Drug | 17-hydroxypregnenolone sulfate | 4.03e-05 | 3 | 84 | 2 | CID000152971 | |
| Drug | RO5126766 | 4.03e-05 | 3 | 84 | 2 | ctd:C577924 | |
| Drug | rabeprazole | 4.50e-05 | 19 | 84 | 3 | CID000005029 | |
| Disease | Colorectal Carcinoma | LPIN1 PROM1 TCERG1L PTPRD PTPRS PEG3 MCF2L2 TPX2 SETD4 CORO1B DMD ZNF292 | 6.20e-07 | 702 | 83 | 12 | C0009402 |
| Disease | epiandrosterone sulfate measurement | 7.04e-07 | 25 | 83 | 4 | EFO_0021120 | |
| Disease | cystatin-SN measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0008106 | |
| Disease | cystatin-D measurement | 1.42e-05 | 17 | 83 | 3 | EFO_0008103 | |
| Disease | metabolonic lactone sulfate measurement | 2.01e-05 | 19 | 83 | 3 | EFO_0800659 | |
| Disease | myoglobinuria (implicated_via_orthology) | 2.34e-05 | 3 | 83 | 2 | DOID:0080108 (implicated_via_orthology) | |
| Disease | small intestine adenocarcinoma (is_implicated_in) | 2.34e-05 | 3 | 83 | 2 | DOID:4906 (is_implicated_in) | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 3.18e-05 | 22 | 83 | 3 | EFO_0021115 | |
| Disease | dehydroepiandrosterone sulphate measurement | 4.13e-05 | 68 | 83 | 4 | EFO_0007001 | |
| Disease | tacrolimus measurement | 4.67e-05 | 4 | 83 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 4.67e-05 | 4 | 83 | 2 | EFO_0007971 | |
| Disease | azoospermia (implicated_via_orthology) | 5.98e-05 | 27 | 83 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | tauro-beta-muricholate measurement | 7.77e-05 | 5 | 83 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 7.77e-05 | 5 | 83 | 2 | EFO_0800569 | |
| Disease | nephrotic syndrome (is_implicated_in) | 7.77e-05 | 5 | 83 | 2 | DOID:1184 (is_implicated_in) | |
| Disease | intellectual disability (is_implicated_in) | 8.25e-05 | 30 | 83 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | androsterone sulfate measurement | 1.10e-04 | 33 | 83 | 3 | EFO_0021117 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 1.16e-04 | 6 | 83 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 1.16e-04 | 6 | 83 | 2 | EFO_0800294 | |
| Disease | cystatin C measurement | 1.41e-04 | 402 | 83 | 7 | EFO_0004617 | |
| Disease | X-24574 measurement | 1.63e-04 | 7 | 83 | 2 | EFO_0800897 | |
| Disease | cystatin-SA measurement | 2.16e-04 | 8 | 83 | 2 | EFO_0008105 | |
| Disease | RASopathy (implicated_via_orthology) | 2.78e-04 | 9 | 83 | 2 | DOID:0080690 (implicated_via_orthology) | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 2.78e-04 | 9 | 83 | 2 | EFO_0800278 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 3.47e-04 | 10 | 83 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 3.47e-04 | 10 | 83 | 2 | EFO_0800289 | |
| Disease | Noonan Syndrome 1 | 4.23e-04 | 11 | 83 | 2 | C4551602 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 4.23e-04 | 11 | 83 | 2 | EFO_0801531 | |
| Disease | phosphatidylcholine 32:0 measurement | 4.23e-04 | 11 | 83 | 2 | EFO_0010372 | |
| Disease | Turner Syndrome, Male | 4.23e-04 | 11 | 83 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 4.23e-04 | 11 | 83 | 2 | C1527404 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 4.23e-04 | 11 | 83 | 2 | EFO_0800295 | |
| Disease | middle cerebral artery infarction (is_implicated_in) | 5.07e-04 | 12 | 83 | 2 | DOID:3525 (is_implicated_in) | |
| Disease | methionine sulfone measurement | 5.07e-04 | 12 | 83 | 2 | EFO_0800072 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 5.07e-04 | 12 | 83 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 5.98e-04 | 13 | 83 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 5.98e-04 | 13 | 83 | 2 | EFO_0800284 | |
| Disease | X-21470 measurement | 6.96e-04 | 14 | 83 | 2 | EFO_0800817 | |
| Disease | unipolar depression, anxiety | 6.96e-04 | 14 | 83 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 6.96e-04 | 14 | 83 | 2 | EFO_0800283 | |
| Disease | non-lobar intracerebral hemorrhage | 7.55e-04 | 63 | 83 | 3 | EFO_0010178 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 8.02e-04 | 15 | 83 | 2 | EFO_0800301 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 8.02e-04 | 15 | 83 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | Unipolar Depression | 8.33e-04 | 259 | 83 | 5 | C0041696 | |
| Disease | Diabetic Angiopathies | 9.14e-04 | 16 | 83 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 9.14e-04 | 16 | 83 | 2 | C0025945 | |
| Disease | X-21410 measurement | 9.14e-04 | 16 | 83 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 9.14e-04 | 16 | 83 | 2 | EFO_0800305 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.03e-03 | 17 | 83 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.16e-03 | 18 | 83 | 2 | EFO_0800288 | |
| Disease | epilepsy (implicated_via_orthology) | 1.17e-03 | 163 | 83 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | phosphatidylcholine measurement | 1.26e-03 | 284 | 83 | 5 | EFO_0010226 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.30e-03 | 19 | 83 | 2 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.30e-03 | 19 | 83 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.30e-03 | 19 | 83 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 1.30e-03 | 19 | 83 | 2 | C0587248 | |
| Disease | etiocholanolone glucuronide measurement | 1.30e-03 | 19 | 83 | 2 | EFO_0800362 | |
| Disease | androsterone glucuronide measurement | 1.44e-03 | 20 | 83 | 2 | EFO_0800317 | |
| Disease | gestational age, birth measurement | 1.59e-03 | 21 | 83 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | LEOPARD Syndrome | 1.74e-03 | 22 | 83 | 2 | C0175704 | |
| Disease | X-24947 measurement | 1.74e-03 | 22 | 83 | 2 | EFO_0800910 | |
| Disease | Attention deficit hyperactivity disorder | 2.07e-03 | 24 | 83 | 2 | C1263846 | |
| Disease | aspartate measurement | 2.07e-03 | 24 | 83 | 2 | EFO_0010462 | |
| Disease | temperament and character inventory | 2.07e-03 | 24 | 83 | 2 | EFO_0004825 | |
| Disease | Noonan Syndrome | 2.07e-03 | 24 | 83 | 2 | C0028326 | |
| Disease | birth weight, parental genotype effect measurement | 2.14e-03 | 192 | 83 | 4 | EFO_0004344, EFO_0005939 | |
| Disease | response to interferon | 2.25e-03 | 25 | 83 | 2 | EFO_0007859 | |
| Disease | gout | 2.30e-03 | 196 | 83 | 4 | EFO_0004274 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKDPQENIFLCQALR | 271 | Q6UWZ7 | |
| AKQEPERNECFLQHK | 116 | P02768 | |
| PQKQCREEVLKNFTD | 456 | Q9UL18 | |
| QERADFCPFKVVDNK | 726 | Q12802 | |
| KFRHVFGQPVKNDQC | 11 | Q9BR76 | |
| CFQFANNKPEIEAAL | 3266 | P11532 | |
| CFKQFQQKDFRLPQT | 41 | Q6NXP0 | |
| DFVNKCLIKNPAERA | 336 | Q02750 | |
| DFQEFVNKCLIKNPA | 341 | P36507 | |
| KALFFPCKAAELVNN | 181 | Q13702 | |
| KFDLNKPVRVCNICF | 1146 | Q9P2R3 | |
| NLSLNDCFKKVPRDE | 196 | A8MTJ6 | |
| VRQNTKFFFDPVRKC | 191 | Q9NRZ9 | |
| CSNFDKEFLNEKPRL | 661 | Q04759 | |
| ENPCRKFQANIFNKS | 6 | Q6WCQ1 | |
| RKNPRKFVCLNDNID | 1141 | Q3T906 | |
| SCILQEPKRNLAFFQ | 411 | O14920 | |
| FVKLKQLCVNEPFEE | 346 | Q9NXD2 | |
| SIPCRKRKVLNNFDF | 91 | Q96MR6 | |
| NFLQEKDFCPLDRKR | 76 | Q8N448 | |
| CKLTNEDVKQKQPFF | 426 | Q9NXV6 | |
| CPENFIHFNNKLVIK | 1051 | Q8IY21 | |
| RTACFIKEQPQAQEK | 146 | Q86UF4 | |
| LIRVLQNFSFKPCKE | 456 | P08684 | |
| NRTFLKELEKCAENP | 681 | Q86YR7 | |
| KDLEQIFCQFDPKLE | 311 | Q9ULD0 | |
| LPQKEARFKAFNTCI | 231 | Q9UKL2 | |
| LPQKEARFKAFNTCI | 231 | Q9H2C5 | |
| DFCQLVAQKQKRPTD | 206 | Q96E22 | |
| VLKCFVNRNPKIIFD | 486 | Q8IYU2 | |
| FCNTFRPVDDKEQRK | 796 | Q9P1Y6 | |
| TDDKKCTNRVFIFNP | 456 | O60662 | |
| KVQCLTDIKNLFFPN | 776 | Q14693 | |
| QKCFVFDRPINDKKL | 231 | Q8N8V2 | |
| FIKEFLQPNKCFLEQ | 351 | P29728 | |
| KEQARNKCKDFRQFF | 1026 | Q9GZU2 | |
| RFISANLPCNKFKNR | 1696 | Q13332 | |
| NVKDALKRFLDNPCR | 296 | Q8NGG1 | |
| FCPNKVEFIKNSLNI | 266 | P48547 | |
| EKFQAECALKFPNRQ | 1271 | Q9P2K1 | |
| IKPFEEKCNKRFLVN | 356 | Q5JSL3 | |
| VIRALQNFSFKPCKE | 456 | Q9HB55 | |
| CIQQQDPAFKKRFLD | 631 | Q5THR3 | |
| RQAIFPKLLCQNAED | 351 | Q5VU57 | |
| DSPEFKEQFKLCINR | 706 | Q6P1N0 | |
| FENRENLKEKLAPTC | 2191 | Q0VDD8 | |
| PLCAADIQDQLKKRF | 66 | O15068 | |
| QFFKISPDLNIKCER | 751 | Q69YH5 | |
| ANKIVPFFKLCDEQL | 2066 | Q14204 | |
| KNKFLIDGFPRNQDN | 86 | P30085 | |
| LVRVLQNFSFKPCKE | 456 | P24462 | |
| FHEQPELQKKQLCSF | 106 | P09228 | |
| FHEQPELQKKQLCSF | 106 | P01037 | |
| QEVKFVKDCPRNLIF | 81 | Q5T890 | |
| FHEQPELQKKQLCSF | 106 | P01036 | |
| FISANLPCNKFKNRL | 1656 | P10586 | |
| FISANLPCNKFKNRL | 1661 | P23468 | |
| QKEKCFEPQLLRFFH | 131 | P00748 | |
| DFDRLQFCPKDTQLK | 116 | Q6P1N9 | |
| ADQNLKFIDPFCKIA | 186 | Q14684 | |
| RLCDNCKKEIPVFNF | 11 | O14545 | |
| EKNECRKQPFQRAIG | 2071 | Q9P212 | |
| RQKENGPFLRKCFAI | 146 | O43490 | |
| KARKFQDSNLAPACF | 41 | Q9NVD3 | |
| CNRADFKANQEILPI | 436 | Q13733 | |
| FRIFQTCDEKKFQLP | 46 | Q9ULY5 | |
| DKRIPNCKIFFNNSF | 156 | Q5VWI1 | |
| ISELCKQFRLPFNVK | 446 | Q8N1K5 | |
| DADCFQPAVKRAKLQ | 341 | P32780 | |
| FRQQLHPAQKNFCKN | 241 | Q8NHY6 | |
| SFCNEIDSRKLPQFK | 256 | Q96T68 | |
| NFCFLKLKNSQVRIP | 21 | Q6ZQY7 | |
| FNQLCQKAPRFKDFQ | 276 | Q70EL2 | |
| NIQFNDKVNKPFVCQ | 1891 | O60281 | |
| EAQNRPFDSKKACFV | 26 | Q9UKX3 | |
| LQNPETCEIFKREKN | 1066 | Q8N9V7 | |
| EFCQALQQPDAKVFK | 936 | O43592 | |
| CLSQKQFKEQFPDIS | 516 | Q15650 | |
| DEKDNCQLLFNPRQA | 751 | P35442 | |
| FKNLFRKFENLTDPC | 541 | Q9UHV5 | |
| NKINCIRPDAFQDLQ | 391 | O75093 | |
| LRNGVKFCKVQNFPE | 596 | Q8TEY7 | |
| QKAKEFVCFLLQEDP | 3021 | O75962 | |
| KPFECQKCRKSFNQL | 431 | Q2M3W8 | |
| LRQQKEAACFKARPN | 616 | Q9ULW0 | |
| FKIECLNDIKNLFAP | 786 | Q92539 |